Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 29 | 2024 | 8606 | 2.370 |
Why?
|
Astrocytes | 6 | 2024 | 1341 | 1.210 |
Why?
|
Metformin | 3 | 2024 | 910 | 0.760 |
Why?
|
Memory Disorders | 2 | 2019 | 1198 | 0.760 |
Why?
|
Dementia | 4 | 2023 | 2684 | 0.750 |
Why?
|
Microglia | 7 | 2024 | 1358 | 0.740 |
Why?
|
Apolipoproteins E | 4 | 2021 | 1443 | 0.720 |
Why?
|
Receptors, CXCR | 1 | 2019 | 52 | 0.660 |
Why?
|
Genomics | 5 | 2024 | 5829 | 0.660 |
Why?
|
Nerve Degeneration | 2 | 2020 | 747 | 0.610 |
Why?
|
Brain | 21 | 2024 | 27094 | 0.580 |
Why?
|
Macrophage-1 Antigen | 1 | 2018 | 286 | 0.570 |
Why?
|
Nootropic Agents | 1 | 2018 | 157 | 0.560 |
Why?
|
Plaque, Amyloid | 6 | 2024 | 762 | 0.530 |
Why?
|
Neurodegenerative Diseases | 2 | 2020 | 1085 | 0.470 |
Why?
|
Haplotypes | 1 | 2020 | 2715 | 0.430 |
Why?
|
Amyloid beta-Peptides | 8 | 2024 | 3841 | 0.400 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1885 | 0.390 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 3089 | 0.390 |
Why?
|
Models, Statistical | 2 | 2023 | 5081 | 0.380 |
Why?
|
Neurofibrillary Tangles | 3 | 2023 | 457 | 0.370 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2223 | 0.360 |
Why?
|
Disease Progression | 2 | 2024 | 13511 | 0.350 |
Why?
|
Neurons | 5 | 2020 | 9429 | 0.350 |
Why?
|
Internet | 5 | 2024 | 3096 | 0.330 |
Why?
|
Energy Metabolism | 1 | 2020 | 2877 | 0.330 |
Why?
|
Frontotemporal Dementia | 2 | 2024 | 245 | 0.330 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3412 | 0.320 |
Why?
|
Semantics | 2 | 2012 | 612 | 0.310 |
Why?
|
Calcineurin | 2 | 2019 | 229 | 0.290 |
Why?
|
Database Management Systems | 1 | 2008 | 256 | 0.290 |
Why?
|
Proteomics | 5 | 2024 | 3840 | 0.280 |
Why?
|
Information Storage and Retrieval | 2 | 2012 | 820 | 0.280 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2017 | 141 | 0.260 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2024 | 1462 | 0.250 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12676 | 0.230 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9417 | 0.220 |
Why?
|
Pick Disease of the Brain | 1 | 2024 | 42 | 0.220 |
Why?
|
Administration, Intravesical | 1 | 2023 | 91 | 0.210 |
Why?
|
Dimethyl Sulfoxide | 1 | 2024 | 251 | 0.210 |
Why?
|
Cryoprotective Agents | 1 | 2024 | 128 | 0.210 |
Why?
|
Humans | 49 | 2024 | 761222 | 0.190 |
Why?
|
Receptors, GABA | 2 | 2022 | 312 | 0.180 |
Why?
|
Aged | 16 | 2024 | 169292 | 0.180 |
Why?
|
Cyclohexylamines | 1 | 2020 | 21 | 0.180 |
Why?
|
Probability | 2 | 2023 | 2478 | 0.180 |
Why?
|
Mice | 16 | 2024 | 81330 | 0.180 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2020 | 88 | 0.180 |
Why?
|
BCG Vaccine | 1 | 2023 | 369 | 0.170 |
Why?
|
Information Dissemination | 1 | 2008 | 1129 | 0.170 |
Why?
|
Software | 2 | 2011 | 4431 | 0.170 |
Why?
|
Phenylenediamines | 1 | 2020 | 88 | 0.170 |
Why?
|
Alleles | 2 | 2021 | 6857 | 0.170 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3390 | 0.160 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2019 | 87 | 0.160 |
Why?
|
Apolipoprotein E4 | 1 | 2023 | 709 | 0.160 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 550 | 0.150 |
Why?
|
Carbolines | 1 | 2020 | 295 | 0.150 |
Why?
|
Lewy Body Disease | 1 | 2020 | 247 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17897 | 0.150 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 257 | 0.150 |
Why?
|
Animals | 22 | 2024 | 168089 | 0.150 |
Why?
|
Computational Biology | 4 | 2024 | 3499 | 0.150 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2019 | 158 | 0.150 |
Why?
|
Mitochondrial Membranes | 1 | 2019 | 176 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 988 | 0.150 |
Why?
|
Aging | 4 | 2021 | 8702 | 0.140 |
Why?
|
Parkinson Disease | 1 | 2011 | 2867 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 454 | 0.140 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 184 | 0.140 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58952 | 0.140 |
Why?
|
Neuropeptides | 1 | 2023 | 944 | 0.140 |
Why?
|
RNA, Messenger | 4 | 2024 | 12747 | 0.140 |
Why?
|
Transcription Factor TFIIIA | 1 | 2016 | 24 | 0.140 |
Why?
|
Neuroglia | 2 | 2019 | 953 | 0.140 |
Why?
|
Antimalarials | 1 | 2023 | 907 | 0.140 |
Why?
|
Biomedical Research | 3 | 2024 | 3434 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 580 | 0.130 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18222 | 0.130 |
Why?
|
Administration, Intranasal | 1 | 2018 | 476 | 0.130 |
Why?
|
Down Syndrome | 1 | 2024 | 901 | 0.130 |
Why?
|
Muscular Dystrophies | 1 | 2018 | 391 | 0.130 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2018 | 254 | 0.130 |
Why?
|
Cognition | 3 | 2023 | 6988 | 0.130 |
Why?
|
Membrane Transport Proteins | 2 | 2019 | 1031 | 0.130 |
Why?
|
Male | 21 | 2024 | 360703 | 0.130 |
Why?
|
Genome, Fungal | 1 | 1997 | 202 | 0.130 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2023 | 893 | 0.120 |
Why?
|
Homozygote | 1 | 2020 | 1775 | 0.120 |
Why?
|
Databases, Factual | 2 | 2008 | 7965 | 0.120 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2021 | 1318 | 0.120 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 727 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 731 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1658 | 0.120 |
Why?
|
Synapses | 2 | 2021 | 1755 | 0.110 |
Why?
|
Cerebrovascular Disorders | 1 | 2021 | 1474 | 0.110 |
Why?
|
Random Allocation | 1 | 2018 | 2393 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2022 | 1163 | 0.110 |
Why?
|
Presenilin-1 | 1 | 2017 | 660 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2024 | 18927 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1087 | 0.110 |
Why?
|
Female | 16 | 2024 | 392552 | 0.110 |
Why?
|
Mitochondria | 3 | 2024 | 3620 | 0.110 |
Why?
|
Europe | 1 | 2020 | 3423 | 0.100 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1028 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 36415 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15841 | 0.100 |
Why?
|
Histones | 2 | 2013 | 2570 | 0.100 |
Why?
|
tau Proteins | 2 | 2024 | 2094 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2731 | 0.100 |
Why?
|
Memory, Short-Term | 1 | 2018 | 982 | 0.090 |
Why?
|
Delirium | 1 | 2023 | 1668 | 0.090 |
Why?
|
Ubiquitins | 1 | 2013 | 366 | 0.090 |
Why?
|
Inflammation | 3 | 2020 | 10759 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2049 | 0.090 |
Why?
|
Survival Analysis | 1 | 2023 | 10088 | 0.090 |
Why?
|
Mice, Transgenic | 6 | 2019 | 9520 | 0.090 |
Why?
|
Medical Informatics Applications | 1 | 2012 | 179 | 0.090 |
Why?
|
Memory | 1 | 2020 | 2190 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6504 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2024 | 12341 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2023 | 5295 | 0.080 |
Why?
|
Huntington Disease | 2 | 2013 | 1145 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12159 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2054 | 0.080 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14610 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12474 | 0.080 |
Why?
|
Cohort Studies | 2 | 2023 | 41496 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3594 | 0.080 |
Why?
|
Axons | 1 | 2016 | 1671 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2576 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1005 | 0.070 |
Why?
|
Seizures | 1 | 2021 | 2965 | 0.070 |
Why?
|
Middle Aged | 8 | 2024 | 220858 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2018 | 2725 | 0.070 |
Why?
|
Proteins | 2 | 2000 | 5993 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5719 | 0.070 |
Why?
|
Cytokines | 2 | 2018 | 7386 | 0.070 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2227 | 0.070 |
Why?
|
Corpus Striatum | 1 | 2012 | 1234 | 0.060 |
Why?
|
Saccharomyces cerevisiae | 1 | 1997 | 2667 | 0.060 |
Why?
|
Algorithms | 3 | 2023 | 14025 | 0.060 |
Why?
|
Blood Pressure | 1 | 2021 | 8479 | 0.060 |
Why?
|
Electroencephalography | 1 | 2021 | 6242 | 0.060 |
Why?
|
Genotype | 1 | 2020 | 12985 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2011 | 1393 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2916 | 0.060 |
Why?
|
United States | 3 | 2024 | 72341 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4822 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16575 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3610 | 0.060 |
Why?
|
Genome | 1 | 2012 | 1738 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20118 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6774 | 0.060 |
Why?
|
Ethyl Ethers | 1 | 2023 | 20 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 22128 | 0.060 |
Why?
|
Stathmin | 1 | 2024 | 70 | 0.060 |
Why?
|
Caenorhabditis elegans | 3 | 2023 | 1453 | 0.060 |
Why?
|
Longevity | 2 | 2023 | 1063 | 0.060 |
Why?
|
Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.060 |
Why?
|
Ethers | 1 | 2023 | 73 | 0.050 |
Why?
|
Chromogranin A | 1 | 2023 | 47 | 0.050 |
Why?
|
Solitary Nucleus | 1 | 2023 | 54 | 0.050 |
Why?
|
Genetic Loci | 1 | 2012 | 2623 | 0.050 |
Why?
|
Chromogranins | 1 | 2023 | 160 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3976 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2023 | 287 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2024 | 3114 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2022 | 219 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2022 | 233 | 0.040 |
Why?
|
Gliosis | 1 | 2021 | 245 | 0.040 |
Why?
|
Oleic Acid | 1 | 2020 | 92 | 0.040 |
Why?
|
Apoptosis | 1 | 2016 | 9478 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2024 | 793 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2023 | 696 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2024 | 1577 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 616 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14392 | 0.040 |
Why?
|
Models, Molecular | 2 | 2000 | 5406 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2020 | 271 | 0.040 |
Why?
|
Aldehydes | 1 | 2020 | 170 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15920 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23419 | 0.040 |
Why?
|
RNA Splicing | 1 | 2024 | 896 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 822 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2020 | 295 | 0.040 |
Why?
|
Presenilins | 1 | 2019 | 53 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3552 | 0.040 |
Why?
|
Hospitals, General | 1 | 2023 | 799 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 697 | 0.040 |
Why?
|
Myotonic Dystrophy | 1 | 2018 | 78 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2024 | 875 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 752 | 0.040 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 305 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 734 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1651 | 0.040 |
Why?
|
Methanococcus | 1 | 1997 | 10 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2022 | 11067 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 982 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3744 | 0.040 |
Why?
|
Medical Records | 1 | 2022 | 1409 | 0.040 |
Why?
|
Permeability | 1 | 2019 | 721 | 0.030 |
Why?
|
Glycolysis | 1 | 2021 | 836 | 0.030 |
Why?
|
Cytosol | 1 | 2020 | 883 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1636 | 0.030 |
Why?
|
Independent Living | 1 | 2021 | 579 | 0.030 |
Why?
|
Caloric Restriction | 1 | 2019 | 299 | 0.030 |
Why?
|
HIV Infections | 1 | 2023 | 17348 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 2018 | 390 | 0.030 |
Why?
|
Serotonin | 1 | 2021 | 1042 | 0.030 |
Why?
|
Suppression, Genetic | 1 | 2016 | 190 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7571 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1743 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2021 | 852 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2016 | 130 | 0.030 |
Why?
|
Antioxidants | 1 | 2024 | 1667 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2024 | 2881 | 0.030 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2018 | 265 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 855 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1010 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2000 | 2175 | 0.030 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6586 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14675 | 0.030 |
Why?
|
Cell Survival | 1 | 2024 | 5778 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3777 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2189 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 593 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2224 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3320 | 0.030 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2019 | 1111 | 0.030 |
Why?
|
Open Reading Frames | 1 | 1997 | 811 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13402 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3584 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3778 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1598 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2452 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1997 | 908 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5032 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2018 | 1749 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1026 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3331 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2019 | 870 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1605 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15308 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1610 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11855 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1327 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7046 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5103 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 848 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8300 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4243 | 0.020 |
Why?
|
Acetylation | 1 | 2012 | 1050 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29688 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2018 | 3388 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3571 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80675 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2640 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1807 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2724 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6224 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 775 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54437 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1997 | 2691 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4384 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9567 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1495 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 8998 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3754 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4567 | 0.020 |
Why?
|
MicroRNAs | 1 | 2021 | 3758 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2012 | 1741 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74241 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3446 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16954 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22174 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3430 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10707 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15637 | 0.010 |
Why?
|
Retinoid X Receptors | 1 | 2000 | 91 | 0.010 |
Why?
|
Receptors, Retinoic Acid | 1 | 2000 | 224 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39957 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7571 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 887 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2000 | 924 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17598 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64681 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30004 | 0.010 |
Why?
|
Binding Sites | 1 | 2000 | 5988 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2000 | 2974 | 0.010 |
Why?
|
Adult | 1 | 2021 | 221120 | 0.000 |
Why?
|
Transcription Factors | 1 | 2000 | 12101 | 0.000 |
Why?
|